&nbsp;

obsp-10-7-20.html

Jul 2020

Chimeric Antigen Receptor (CAR) T-cell Therapy Services

Guidelines and Advice

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Status: Current
ID: ES 23-2
Version: N/A

Dec 1969

Document

CAR T Cell Therapy Appeals Policy Apr2020 _ FR.pdf

Jul 2020

Document

ocs-2020-ch1-2-g.png

Dec 1969

Document

obsp-18-8-20.xml

Dec 1969

Document

obsp-18-8-20.html

Dec 1969

Regimen

CRBPGEMC+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

Drugs Used:

pembrolizumab (PDRP prior authorization),

CARBOplatin,

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Regimen

CISPGEMC+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

Drugs Used:

pembrolizumab (PDRP prior authorization),

CISplatin,

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Regimen

CHP+BREN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade,

Lymphoma - T-cell

Intent: Curative, Palliative

Funding:

New Drug Funding Program

Brentuximab Vedotin - In Combination with Chemotherapy for Previously Untreated Peripheral T-cell Lymphoma (PTCL)

ODB - General Benefit

prednisone

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2022

Regimen

CYTADAUN+GEMT

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Curative

Funding:

New Drug Funding Program

Gemtuzumab Ozogamicin (Outpatient) - Previously Untreated Acute Myeloid Leukemia

Drugs Used:

DAUNOrubicin,

cytarabine,

gemtuzumab ozogamicin

... Show more tags